APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis

被引:139
作者
Sadler, Holly A. [1 ,2 ]
Stenglein, Mark D. [1 ,3 ,5 ]
Harris, Reuben S. [1 ,3 ,5 ]
Mansky, Louis M. [1 ,2 ,4 ]
机构
[1] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Diagnost & Biol Sci, Sch Dent, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Sch Med, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Microbiol, Sch Med, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION; CYTIDINE DEAMINASES; MUTATIONAL ANALYSIS; DRUG-RESISTANCE; ENZYME APOBEC3G; POOL IMBALANCES; VIF PROTEIN; VIRAL-RNA; IN-VIVO;
D O I
10.1128/JVI.00056-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The mammalian APOBEC3 proteins are an important component of the cellular innate immune response to retroviral infection. APOBEC3G can extinguish HIV-1 infectivity by its incorporation into virus particles and subsequent cytosine deaminase activity that attacks the nascent viral cDNA during reverse transcription, causing lethal mutagenesis. It has been suggested, but not formally shown, that APOBEC3G can also induce sublethal mutagenesis, which would maintain virus infectivity and contribute to HIV-1 variation. To test this, we developed a novel model system utilizing an HIV-1 vector and a panel of APOBEC3G-expressing cells. We observed proviruses with single APOBEC3G-mediated mutations (in the presence or absence of Vif), occurring at distinct hot spots and which could be rescued and shown to have infectivity. These data indicate that APOBEC3G-dependent restriction of HIV-1 can result in viable viral progeny that harbor sublethal levels of G-to-A mutations. Such mutations have the potential to contribute significantly to HIV-1 evolution, pathogenesis, immune escape, and drug resistance.
引用
收藏
页码:7396 / 7404
页数:9
相关论文
共 46 条
  • [1] BEBENEK K, 1992, J BIOL CHEM, V267, P3589
  • [2] BEBENEK K, 1989, J BIOL CHEM, V264, P16948
  • [3] APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
    Bishop, Kate N.
    Verma, Mohit
    Kim, Eun-Young
    Wolinsky, Steven M.
    Malim, Michael H.
    [J]. PLOS PATHOGENS, 2008, 4 (12):
  • [4] Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent
    Browne, Edward P.
    Allers, Carolina
    Landau, Nathaniel R.
    [J]. VIROLOGY, 2009, 387 (02) : 313 - 321
  • [5] Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass
    Cancio, R
    Spadari, S
    Maga, G
    [J]. BIOCHEMICAL JOURNAL, 2004, 383 : 475 - 482
  • [6] New directions in polycystic ovary syndrome - Introductoon to guest editor
    Carr, Bruce R.
    [J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2008, 26 (01) : 1 - 1
  • [7] Human immunodeficiency virus 1 (HIV-1) virion infectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcription
    Carr, Jillian M.
    Coolen, Carl
    Davis, Adam J.
    Burrell, Christopher J.
    Li, Peng
    [J]. VIROLOGY, 2008, 372 (01) : 147 - 156
  • [8] The interaction between HIV-1 Gag and APOBEC3G
    Cen, S
    Guo, F
    Niu, MJ
    Saadatmand, J
    Deflassieux, J
    Kleiman, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) : 33177 - 33184
  • [9] MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM DIFFERENT PATIENTS EXHIBIT UNUSUAL V3 ENVELOPE SEQUENCE HOMOGENEITY IN COMPARISON WITH T-CELL-TROPIC ISOLATES - DEFINITION OF CRITICAL AMINO-ACIDS INVOLVED IN CELL TROPISM
    CHESEBRO, B
    WEHRLY, K
    NISHIO, J
    PERRYMAN, S
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (11) : 6547 - 6554
  • [10] The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements
    Chiu, Ya-Lin
    Greene, Warner C.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2008, 26 : 317 - 353